Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Acheson

Showing results (21-30 of 22) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 22 results.
International Journal of Oncology|May 4, 2011
Vandetanib inhibits both VEGFR-2 and EGFR signalling at clinically relevant drug levels in preclinical models of human cancerSandra R Brave, Rajesh Odedra, Neil H James, et al.
Clinical and Translational Science|May 7, 2010
Identification of biomarkers in human head and neck tumor cell lines that predict for in vitro sensitivity to gefitinibD Mark Hickinson, Gayle B Marshall, Garry J Beran, et al.
Pageof 3

Showing results (21-30 of 22) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 22 results.
International Journal of Oncology|May 4, 2011
Vandetanib inhibits both VEGFR-2 and EGFR signalling at clinically relevant drug levels in preclinical models of human cancerSandra R Brave, Rajesh Odedra, Neil H James, et al.
Clinical and Translational Science|May 7, 2010
Identification of biomarkers in human head and neck tumor cell lines that predict for in vitro sensitivity to gefitinibD Mark Hickinson, Gayle B Marshall, Garry J Beran, et al.
Pageof 3